270 related articles for article (PubMed ID: 22863432)
1. Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease.
Zhou W; Ni Z; Yu Z; Shi B; Wang Q
Eur J Intern Med; 2012 Sep; 23(6):539-44. PubMed ID: 22863432
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.
Hayashi M; Yasuda Y; Suzuki S; Tagaya M; Ito T; Kamada T; Yoshinaga M; Sugishita Y; Fujiwara W; Yokoi H; Ozaki Y; Izawa H
Heart Vessels; 2017 Mar; 32(3):279-286. PubMed ID: 27385024
[TBL] [Abstract][Full Text] [Related]
3. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
[TBL] [Abstract][Full Text] [Related]
4. Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease.
Zhang M; Ni Z; Zhou W; Qian J
J Biomed Sci; 2015 Sep; 22(1):75. PubMed ID: 26381729
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
[TBL] [Abstract][Full Text] [Related]
6. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
7. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients.
Ng YM; Lim SK; Kang PS; Kadir KA; Tai MS
BMC Nephrol; 2016 Oct; 17(1):151. PubMed ID: 27756244
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease.
Li X; Yang XC; Sun QM; Chen XD; Li YC
Chin Med J (Engl); 2013 Mar; 126(5):823-7. PubMed ID: 23489784
[TBL] [Abstract][Full Text] [Related]
9. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of brain natriuretic peptide to renal function and left ventricular hypertrophy in patients with chronic kidney disease].
Zhou WY; Ni ZH; Gu LY; Fang W; Wang Q; Mou S; Cao LO; Yu ZZ; Qian JQ
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3284-7. PubMed ID: 18396626
[TBL] [Abstract][Full Text] [Related]
12. N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.
Pastormerlo LE; Maffei S; Latta DD; Chubuchny V; Susini C; Berti S; Clerico A; Prontera C; Passino C; Januzzi JL; Emdin M; Chiappino D
Eur J Prev Cardiol; 2016 Mar; 23(4):366-76. PubMed ID: 25644699
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
14. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
[TBL] [Abstract][Full Text] [Related]
15. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
16. Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis.
Kabłak-Ziembicka A; Przewłocki T; Stępień E; Pieniążek P; Rzeźnik D; Sliwiak D; Komar M; Tracz W; Podolec P
Kardiol Pol; 2011; 69(10):1024-31. PubMed ID: 22006602
[TBL] [Abstract][Full Text] [Related]
17. Plasma creatinine levels, estimated glomerular filtration rate and carotid intima media thickness in middle-aged women: a population based cohort study.
Gentile M; Panico S; Mattiello A; de Michele M; Iannuzzi A; Jossa F; Marotta G; Rubba P
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):677-80. PubMed ID: 24472637
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
[TBL] [Abstract][Full Text] [Related]
19. Chronic Kidney Disease and Carotid Atherosclerosis in Patients With Acute Stroke.
Yu FP; Zhao YC; Gu B; Hu J; Yang YY
Neurologist; 2015 Aug; 20(2):23-6. PubMed ID: 26280286
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease.
Yadav AK; Banerjee D; Lal A; Jha V
Nephrology (Carlton); 2012 Aug; 17(6):575-81. PubMed ID: 22489804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
